Source: Annual Congress 2011 - Endoscopic lung volume reduction: hype or hope?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Herth, G. Snell, P. Hopkins, K. Baker, C. Witt, M. H. Gotfried, A. Valipour, M. Wagner, F. Stanzel, J. Egan, S. Kesten, A. Ernst (Heidelberg, Berlin, Nuremberg, Hemer, Germany; Melbourne, Chermside, Australia; Iowa City, Phoenix, Tustin, Boston, United States Of America; Vienna, Austria; Dublin, Ireland). Sustained efficacy from 3 to 6 months following bronchoscopic thermal vapor ablation (BTVA) in the treatment of heterogeneous emphysema. Eur Respir J 2011; 38: Suppl. 55, 370

Member's Comments

No comment yet.

Related content which might interest you: Associations of efficacy outcomes following bronchoscopic thermal vapor ablation (BTVA) for the treatment of heterogeneous emphysema Source: Annual Congress 2011 - Treatment beyond inhalers: endoscopic lung volume reduction Year: 2011 The influence of baseline exercise tolerance on long-term efficacy outcomes following endoscopic thermal vapor ablation (InterVaporÔ) in patients with heterogeneous emphysema Source: Annual Congress 2012 - Endoscopic lung volume reduction: the growing evidence Year: 2012 Associations among one-year efficacy outcomes following endoscopic thermal vapor ablation (InterVaporÔ) for heterogeneous emphysema Source: Annual Congress 2012 - Endoscopic lung volume reduction: the growing evidence Year: 2012 The influence of emphysema heterogeneity on the magnitude of benefit following endoscopic thermal vapor ablation (InterVaporÔ) in patients with heterogeneous emphysema Source: Annual Congress 2012 - Endoscopic lung volume reduction: the growing evidence Year: 2012 Endoscopic lung volume reduction (ELVR) treatment for patients with severe heterogeneous emphysema and bilateral incomplete fissures. Effectiveness and complications of coils´ implantation at 90 days follow up Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more Year: 2015 6 and 12 month outcomes following RePneu bronchoscopic lung volume reduction coil treatment Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013 6-month follow-up in patients with advanced homogeneous emphysema treated with endobronchial lung sealant therapy Source: Annual Congress 2011 - Endoscopic lung volume reduction: hype or hope? Year: 2011 Germany pilot safety and feasibility study of bronchoscopic thermal vapor ablation (BTVA) for lung volume reduction in patients with heterogeneous emphysema with upper lobe predominance Source: Annual Congress 2009 - Treatment beyond inhalers Year: 2009 Bronchoscopic lung volume reduction coil treatment of severe heterogeneous emphysema Source: Annual Congress 2010 - Interventions for obstructive lung diseases Year: 2010 LATE-BREAKING ABSTRACT: A feasibility and safety study, of bronchoscopic hot saline ablation (BHSA) of emphysematous lung. A different emphysema therapy Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013 Responses to polymeric lung volume reduction (PLVR) therapy at 6 months in patients with GOLD stage III emphysema Source: Annual Congress 2010 - Interventions for obstructive lung diseases Year: 2010 Severe heterogeneous emphysema treated unilaterally with endobronchial coils in patients with bilaterally incomplete fissures. Aiming for long lasting endoscopic lung volume reduction (ELVR); is effectiveness sustained at one year follow-up? Source: International Congress 2014 – Bronchoscopic treatment of emphysema: valves, coils and other Year: 2014 Removal of diseased emphysematous tissue with bronchoscopic thermal vapor ablation (BTVA) Source: International Congress 2018 – Endoscopic lung volume reduction Year: 2018 Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema Source: Eur Respir J 2012; 39: 1326-1333 Year: 2012 Survival benefit from successful bronchoscopic lung volume reduction with endobronchial valves - A 10 year follow up study Source: International Congress 2016 – Endoscopic lung volume reduction II Year: 2016 Effect of biologic lung volume reduction (BLVR) therapy on BODE at 6 and 12 weeks Source: Annual Congress 2008 - COPD Year: 2008 STEP-UP randomized controlled trial of vapor ablation in patients with severe emphysema: 12 month results Source: International Congress 2016 – Endoscopic lung volume reduction I Year: 2016 Evaluation of the Lung Volume Reduction Reverser System (LVR-R) in treating patients with severe emphysema. Feasibility and safety at 6 months follow up; preliminary results Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction Year: 2021 A safety and feasibility study of the chartis system in subjects with heterogeneous emphysema prior to endobronchial lung volume reduction (ELVR) Source: Annual Congress 2009 - Treatment beyond inhalers Year: 2009 Preliminary results of study of bronchoscopic hot saline ablation (BHSA) treatment, in emphysematous lung disease Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more Year: 2015